The erythromycin breath test for the prediction of drug clearance.
about
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response.Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA.Defining CYP3A4 structural responses to substrate binding. Raman spectroscopic studies of a nanodisc-incorporated mammalian cytochrome P450.Interactions of herbs with cytochrome P450.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsPopulation pharmacokinetics of weekly docetaxel in patients with advanced cancer.Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.OATP1B1 polymorphism as a determinant of erythromycin disposition.Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.Influence of solute carriers on the pharmacokinetics of CYP3A4 probes.Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination.In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4.Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity.CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin.Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C14-erythromycin breath test and the antipyrine clearance test
P2860
Q30843051-A7248A62-2D9B-42EF-B7CF-E021E4E90EFBQ33829773-EEBEBE0E-302A-4245-813F-E83E986F5156Q34551011-13A3AE02-D062-4638-9824-A3A097CD4B86Q35085032-7F06385C-7F63-4F70-8074-7003EDEBC678Q35795744-454644AF-6C6C-4823-8D18-DDF94D9B9F24Q35825890-DDFEBC02-A134-4091-A87F-BF090A6971B3Q35827661-66CA9E6C-80FE-4F5D-A07C-0EDCF857E292Q36339094-09980DA2-2502-4492-91AC-F3D061667A6DQ37076331-AFBD0E05-026B-4BB2-B06A-977C1A6DE64BQ37176032-B16BEA89-20F9-4940-89D3-B735A9CBD033Q37733572-2937AC1D-A44F-4F6C-9ECC-9053B440D80BQ45040968-A2CC602F-C561-4BF4-9146-74EF0EA34FDFQ45137094-8BA6CB55-1BBD-4054-A549-18CAEC7F9B33Q45188831-C3965B60-0C59-45D3-BD3F-775BBDC75842Q46181375-29D9E8A7-7271-4A69-88C1-773803232F80Q46711328-996C625D-B3CD-48DC-8DA0-027141E889C0Q48098073-C3A95867-98EE-4846-A639-D3908647B8A4Q51732246-16FFF796-3D97-4B62-8D08-4A970ED417EAQ57265718-E089997C-67ED-4DC0-BFB2-4B4CC4F6D1FB
P2860
The erythromycin breath test for the prediction of drug clearance.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The erythromycin breath test for the prediction of drug clearance.
@ast
The erythromycin breath test for the prediction of drug clearance.
@en
type
label
The erythromycin breath test for the prediction of drug clearance.
@ast
The erythromycin breath test for the prediction of drug clearance.
@en
prefLabel
The erythromycin breath test for the prediction of drug clearance.
@ast
The erythromycin breath test for the prediction of drug clearance.
@en
P2093
P1476
The erythromycin breath test for the prediction of drug clearance.
@en
P2093
Hoskins JM
Slaviero KA
P304
P356
10.2165/00003088-200140030-00001
P577
2001-01-01T00:00:00Z
P6179
1011457640